Clinical Trials Logo

Clinical Trial Summary

To determine whether the use of anti-adhesion barrier after thyroid surgery can prevent the voice changes after surgery, using objective voice-related indicators.

Clinical Trial Description

- Randomized controlled study - Including 40 patients in each arm - Treatment: anti-adhesion barrier apply on the thyroidectomy space - Control: No use of anti-adhesion barrier - Primary outcome: VHI-30 (Voice handicap index) - Secondary outcome: findings from stroboscopy, CSL (Computerize Speech Lab) - Outcome measurement: preoperative, post-operative 3 months, post-operative 9 months. ;

Study Design

Related Conditions & MeSH terms

NCT number NCT04853680
Study type Interventional
Source Inha University Hospital
Contact Jin Wook Yi, Professor
Phone +82-32-890-3437
Email [email protected]
Status Not yet recruiting
Phase N/A
Start date May 1, 2021
Completion date May 30, 2022

See also
  Status Clinical Trial Phase
Not yet recruiting NCT04224792 - Effects of Exercise Training on Fatigue in Thyroid Cancer Survivors N/A
Completed NCT01728623 - A Study of E7080 in Subjects With Advanced Thyroid Cancer Phase 2
Completed NCT02911155 - Cancer and Other Disease Risks in U.S. Nuclear Medicine Technologists
Not yet recruiting NCT03978351 - The Role of Midkine in Diagnosis of Thyroid Cancer
Completed NCT02658513 - Evaluation of Lancet Blood Sampling for Radioiodine Dosimetry in Thyroid Cancer
Terminated NCT02628535 - Safety Study of MGD009 in B7-H3-expressing Tumors Phase 1
Completed NCT02375451 - Effect of Childhood Radioiodine Therapy on Salivary Function N/A
Withdrawn NCT01994200 - Developing and Implementing an Interdisciplinary Team-Based Care Approach (ITCA-ThyCa) for Thyroid Cancer Patients Phase 1/Phase 2
Recruiting NCT01964508 - microRNA in Thyroid Cancer N/A
Terminated NCT01403324 - Comparison of Dosimetry After rhTSH or Withdrawal of Thyroid Hormone in Metastatic or Locally Advanced Thyroid Cancer N/A
Completed NCT00970359 - Reacquisition of Radioactive Iodine (RAI) Uptake of RAI-Refractory Metastatic Thyroid Cancers by Pretreatment With the Selective MEK Inhibitor AZD6244 N/A
Completed NCT00439478 - Dental Safety Profile of High-Dose Radioiodine Therapy Phase 4
Completed NCT00223158 - Evaluation Study of L-T3 Utility in the Follow-up of Patients With Thyroid Cancer N/A
Active, not recruiting NCT03246958 - Nivolumab Plus Ipilimumab in Thyroid Cancer Phase 2
Recruiting NCT04544111 - PDR001 Combination Therapy for Radioiodine-Refractory Thyroid Cancer Phase 2
Completed NCT04876287 - Salivary dysfuncTion After Radioiodine Treatment
Recruiting NCT04552769 - Abemaciclib in Metastatic or Locally Advanced Anaplastic/Undifferentiated Thyroid Cancer Phase 2
Recruiting NCT03345563 - Project HERO: Health Empowerment & Recovery Outcomes N/A
Not yet recruiting NCT04560426 - Protective Effect of Intraoperative Parathyroid Gland Auxiliary Recognition System in Thyroid Malignant Tumor Operation N/A
Not yet recruiting NCT04128631 - Thyroid Cancer and (FDG)PET/CT Scan